pI: 7.9213 |
Length (AA): 872 |
MW (Da): 98198 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
29 | 79 | 2d9n (A) | 67 | 122 | 33.00 | 0 | 1 | 0.250786 | 0.65 |
29 | 75 | 1rgo (A) | 158 | 219 | 43.00 | 0 | 0.85 | 0.144199 | 0.72 |
340 | 528 | 6ekv (A) | 12 | 212 | 12.00 | 0 | 0 | 0.278043 | -0.06 |
763 | 827 | 2dkt (A) | 19 | 67 | 39.00 | 0.29 | 0.04 | 0.0593413 | 0.8 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_132161)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_IV003110 | CHY zinc finger domain containing protein |
Brugia malayi | Bm1_24215 | CHY zinc finger family protein |
Cryptosporidium hominis | Chro.20367 | hypothetical protein |
Cryptosporidium parvum | cgd2_3460 | C- terminal region conserved, zinc finger, myb DNA binding domain |
Echinococcus granulosus | EgrG_001098800 | Zinc finger CCCH type |
Echinococcus multilocularis | EmuJ_001098800 | Zinc finger, CCCH type |
Echinococcus multilocularis | EmuJ_001099000 | hypothetical protein |
Giardia lamblia | GL50803_15295 | Zinc finger protein, putative |
Loa Loa (eye worm) | LOAG_05306 | hypothetical protein |
Loa Loa (eye worm) | LOAG_05307 | hypothetical protein |
Neospora caninum | NCLIV_070000 | zinc finger (CHY type) protein, putative |
Onchocerca volvulus | OVOC7288 |
|
Plasmodium berghei | PBANKA_0831100 | zinc finger protein, putative |
Plasmodium falciparum | PF3D7_0930400 | zinc finger protein, putative |
Plasmodium knowlesi | PKNH_0729000 | zinc finger protein, putative |
Plasmodium vivax | PVX_099985 | hypothetical protein, conserved |
Plasmodium yoelii | PY01869 | homeobox-containing protein |
Plasmodium yoelii | PY01868 | putative zinc finger protein |
Schistosoma japonicum | Sjp_0317950 | expressed protein |
Schistosoma japonicum | Sjp_0051750 | IPR000571,Zinc finger, CCCH-type,domain-containing |
Schistosoma mansoni | Smp_172780 | hypothetical protein |
Toxoplasma gondii | TGME49_306040 | CHY zinc finger protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0831100 | Plasmodium berghei | Dispensable | plasmo |
TGME49_306040 | Toxoplasma gondii | Probably non-essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.